We are developing a diagnostic platform for an early Alzheimer's diagnosis analyzing a pool of epigenetic biomarkers in blood samples.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):